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Often thought to be a nutritional issue limited to low- and middle-income countries (LMICs), pediatric thiamine
deficiency (PTD) is perceived as being eradicated or anecdotal in high-income countries (HICs). In HICs, classic
beriberi cases in breastfed infants by thiamine-deficientmothers living in disadvantaged socioeconomic conditions
are thought to be rare. This study aims to assess PTD inHICs in the 21st century. Literature searcheswere conducted
to identify case reports of PTD observed in HICs and published between 2000 and 2020. The analyzed variables
were age, country, underlying conditions, clinical manifestations of PTD, and response to thiamine supplementa-
tion. One hundred and ten articles were identified, totaling 389 PTD cases that were classified into four age groups:
neonates, infants, children, and adolescents. Eleven categories of PTD-predisposing factors were identified, includ-
ing genetic causes, lifestyle (diabetes, obesity, and excessive consumption of sweetened beverages), eating disorders,
cancer, gastrointestinal disorders/surgeries, critical illness, and artificial nutrition. TD-associated hyperlactatemia
andWernicke encephalopathy were themost frequent clinicalmanifestations. The circumstances surrounding PTD
in HICs differ from classic PTD observed in LMICs and this study delineates its mutiple predisposing factors. Fur-
ther studies are required to estimate its magnitude. Awareness is of utmost importance in clinical practice.
Keywords: pediatric thiamine deficiency; hyperlactatemia; Wernicke encephalopathy; bariatric surgery; sweetened
drinks; anorexia
Introduction
Thiamine, also called vitamin B1 or aneurin, is a
water-soluble vitamin that is an essential micronu-
trient for human beings, who cannot synthesize it
and whose body reserves in tissues can be depleted
within a couple of weeks without adequate thi-
amine intake.1 Thiamine is crucial factor for both
enzymatic and nonenzymatic functions within the
cytosolic, mitochondrial, and peroxisomal com-
partments. Thiamine is involved inmany processes,
particularly in energy transformation and oxida-
tive and nonoxidative carbohydrate metabolism. As
a crucial cofactor in the metabolism of carbohy-
drates and amino acids, its role is extended to fatty
acid metabolism.1,2 The limited body storage in tis-
sues, combined with low intake, contributes to the
propensity to thiamine deficiency (TD) during all
life stages of human beings.
The daily recommended dietary allowance for
thiamine has been revised based on the specific pop-
ulation requirements in some nations, which varies
according to age range, gender, life stage (preg-
nancy and lactation), energy intake (notably carbo-
hydrate intake), and physical activity level (inactive,
moderately inactive, moderately active, and active
occupational physical activity in children).3,4 These
recommended thiamine intakes should cover the
metabolic requirements of themain target organs of
TD: heart, peripheral and central nervous systems,
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muscles, and others.5,6 The brain is particularly
sensitive to any thiamine deprivation, especially
during early childhood and various periods of
adolescence.7
The prevalence of this life-threatening disease is
unevenly distributed around theworld. TD is highly
prevalent in low- and middle-income countries
(LMICs) or in humanitarian emergencies, where
various limited resources cause either malnutrition
or hunger with severe food insecurity.8 It can also
occur in the context of a monotonous diet or diets
that rely on low-thiamine staple foods (e.g., polished
rice), notably in breastfed infantswhosemothers are
thiamine deficient.8–12
Many factors have likely contributed to the reduc-
tion of this public health concern, especially in
high-income countries (HICs), such as significant
advancements in large-scale fortification of widely
consumed foods (e.g., wheat flour), although thi-
amine fortification policies are not mandatory in a
number of countries.13–18 The advances in the diag-
nosis and treatment of Wernicke encephalopathy
(WE) have also contributed to the reduction of its
prevalence and burden.19 As a consequence, there
are no studies that have systematically assessed TD
in pediatric patients in HICs, and there is only
sparse literature in the form of case reports, which
contributes to the perception that pediatric thi-
amine deficiency (PTD) is somewhat anecdotal in
HIC.20–23 There are no accurate statistics available
on the incidence of PTD, which is thought to be
associated with a few underlying conditions.24
Therefore, the aimof this study is to identify cases
of PTD reported in HICs during the past 20 years,
including a description of the ages, causes of TD,
and underlying conditions, as well as clinical mani-
festations of the affected patients.
Methods
An electronic literature search was conducted
on Medline (via Pubmed), Cochrane library, and
Google Scholar using the cross-referenced com-
bination of the following MeSH terms: thiamine
deficiency (TD) or disorders, thiamine metabolism,
dry beriberi, wet beriberi, WE, heart failure,
Shoshin, and lactatemia. Retrieved publications
were screened and selected by two authors, B.R. and
L.H. (and verified by third author F.G.), following
the inclusion criteria: confirmed cases of TD in the
pediatric population that were observed in HICs.
TD was defined as positive clinical response to thi-
amine administration or biochemical confirmation
of TD (including genetic sequencing) or specific
radioimaging findings. The definition of HICs fol-
lowed the World Bank classification,25 where low-
andmiddle- income economies are defined as those
with a gross national income per capita of $12,535
or less and high-income economies are those with a
gross national income per capita of $12,536 ormore.
We followed the American Academy of Pediatrics3
age groups definition but excluded late adolescents
since most of the pediatric units do not report
patients above 18 years of age. Neonate (birth to 28
days old), infancy (1month–2 years old), childhood
(2−11 years old), and adolescence (12−18 years
old) were considered for inclusion.
This paper focused on the clinical aspects of
PTD (as per the study authors’ judgment) and did
not cover either laboratory techniques or discuss
clinical–laboratory agreement.
The searches were limited to studies published
between 2000 and 2020, but there were no lan-
guage restrictions. The extracted variables for the
included studies were: country where the study was
conducted, age of the identified cases, causes of TD
or underlying conditions (which were classified into
categories of predisposing factors), clinicalmanifes-
tations, and response to thiamine supplementation
(as positive or negative, when reported). Variables
were reported as numbers or percentages.
Results
A total number of 110 articles were included, cover-
ing 389 pediatric patients under 19 years old with
confirmed TD in HICs. According to the above-
mentioned methodology, 74% of all reports, not
including genetic sequencing, assessed and had
data available on serum thiamine (49 reports),
whole blood thiamine diphosphate (5 reports), and
erythrocyte transketolase activity coefficient (10
reports).
Country of origin of included studies
The regional distribution of the included publica-
tions is displayed in Figure 1. Most of the studies
originated from theUnited States (32.4% of all stud-
ies), followed by five countries, namely, Japan, Israel,
Italy, Germany, and China. These represent the top
six countries among a total of 23 countries.
58 Ann. N.Y. Acad. Sci. 1498 (2021) 57–76 © 2021 The Authors. Annals of the New York Academy of Sciences
published by Wiley Periodicals LLC on behalf of New York Academy of Sciences
Rakotoambinina et al. Pediatric thiamine deficiency in high-income countries
Figure 1. Percentage of included studies per country (case reports/series of pediatric thiamine deficiency published in 110 papers
between 2000 and 2020).
Patient age distribution
Figure 2 shows that although infants still represent
a large group, the majority of affected PTD patients
in HICs are children and adolescents, as opposed to
PTD observed in LMICs, where the classic infantile
beriberi is well described.
Circumstances surrounding PTD in HICs and
predisposing risk factors (causes or
underlying conditions)
The case reports identified (n= 389) can be divided
into 11 main clinical categories (C0–C10) where
PTDs have been described. In some conditions,
multiple pathophysiological mechanisms might be
involved. Table S1 (online only) presents a sepa-
rate group (C0) of 91 patients described with neu-
rological impairment as a result of earlier TD insult.
Table S2 (online only) summarizes the remaining
298 included cases of PTD (C1–C10) divided by
categories of predisposing risk factors (causes and
underlying conditions), including both genetic thi-
amine disorders and acquired TD reported inHICs.
Figure 3 shows the distributions of included cases
into the 10 (C1–C10) categories of predisposing risk
factors (causes and underlying conditions) of TD.
Below is the description of these 11 categories,
classified from C0 to C10:
C0: PTD as a result of early infancy consumption
of thiamine-free formula, followed up in tertiary
neurocognitive referral settings. This category is
a large group, comprised of mostly young chil-
dren followed up beyond infancy for neurolog-
ical sequelae and disability following TD insults
during early infancy. They present with neuro-
logical and cognitive disorders and are referred
to specialized services tied to neuroimaging
platforms.20,26–30 This category (n = 91) is pre-
sented separately in Table S1 (online only).
C1: PTD caused by genetic inborn errors of thi-
amine metabolism. They account for 22% of all
298 cases and are presented in Table S2 (online
only). As expected, neonates and infants repre-
sent 57% of the 65 reported cases in this category.
Interestingly, children and adolescents represent
35% and 7.7%, respectively.
Using high-throughput genomic screening,
four genetic mutations and their variants have
been described in 19 countries, some of them
with high incidence of inborn errors of thiamine
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Figure 2. Distribution by four pediatric age groups of the overall 389 patients extracted from the 110 included studies (2000–
2020).
metabolism disorders that might be increased by
consanguinity.31,32 These conditions are character-
ized by a variable onset of the disorder and a wide
range of clinical signs, including recurrent episodic
encephalopathy, dystonia, convulsions, ocular
abnormalities, microcephaly, anemia, thrombo-
cythemia, and diabetes.
Three of the genetic mutations encode for thi-
amine transporters, and one encodes for the enzyme
thiamine pyrophosphokinase 1 (TPK1), which con-
verts thiamine into its active form:
1. Mutations in SLC19A2, which cause thiamine-
responsive megaloblastic anemia (TRMA),
were described in eight studies (UK,Denmark,
China, Portugal, Lithuania, United States, Italy,
and Croatia). It is often revealed by a neonatal
diabetic ketoacidosis (DKA).31,33–39
2. Mutations in SLC19A3, which cause
biotin/thiamine-responsive basal ganglia
disease characterized by episodes of severe
Leigh-like encephalopathy, were described in
seven studies from six countries (Spain, Saudi
Arabia, UK, France, Japan, and Norway).40–46
3. Mutations in SLC25A19 (called Amish
microcephaly) were identified in five stud-
ies (Canada, United States, Oman, Israel, and
Germany).47–51 They are characterized by a
very small head at birth, seizures, and episodes
of lactic acidosis.
4. Mutations in TPK1 were found in four
studies (China, United States, Austria,
and Germany).32,52–54 TPK deficiency can
present as episodic encephalopathy or Leigh
syndrome–like early-onset global develop-
mental delay.
C2: PTD related to diabetic patients with ketoaci-
dosis and/or obese patients (7%). In type 1 dia-
betes, the main concern is DKA with the occur-
rence of suboptimal thiamine levels even prior
to insulin therapy. Then, insulin administration
induces PTD. Altered mental status is a com-
mon finding of DKA, and therefore TD-related
encephalopathy could be missed.55,56
C3: PTD after bariatric surgery (2%). Clinical
signs of TD can occur in adolescents in the first
months following surgery. The alerting symp-
toms are intractable vomiting orminor neurolog-
ical signs preceding the onset of WE with associ-
ated hyperlactatemia.57–61
C4: PTD related to total parenteral nutrition
(TPN) or enteral nutrition (EN) (8%) may occur
at any age, even in preterm neonates or very low
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Figure 3. Distribution of the included cases into 10 categories of predisposing risk factors according to the four pediatric age
groups.
birth-weight infants and infants suffering from
gastrointestinal disorders or postoperative prob-
lems. Parenteral/enteral formulations might con-
tain inadequate levels of thiamine for this age
group. These patients can also present signs, such
as the classic form of TD, refractory lactic aci-
dosis, myocardial injuries, shockwithmultiorgan
failure, andWE. Most of the time the abnormali-
ties can be resolved with the rapid administration
of thiamine supplementation.62–68
C5: PTD related to high consumption of sugar-
sweetened beverages or isotonic drinks, either in
infancy or childhood/adolescence (15%).22,69–78
Most of the cases were reported in Japan. A
Japanese survey revealed 33 children with regular
intake of soft drinks who developed dramatic TD
(confirmed by whole blood TDP).77 Of these, TD
was clinically expressed as classical WE in four
cases, one resulted in death, and 12 had long-term
neurological sequelae of TD.
C6: PTD related to eating disorders (anorexia)
(10%).79–84 PTD related to eating disorders con-
sistently occurs during adolescence, based on
case reports. Two large case series referring
to TD-related anorexia were retrieved.79,83 The
largest case series were in pediatric psychiatric
units and the majority of cases suffered from
Wernicke syndrome. The prevalence of biologi-
cally confirmed TD was estimated at 38% of the
37 patients at a specialized pediatric psychiatric
unit,79 while this prevalence only reached 10% in
a prospective study of 39 girls admitted to an out-
patient day hospital for eating disorders.83
C7: PTD related to gastrointestinal disorderswith
reduced thiamine absorption (2%). This encom-
passes a wide panel of clinical conditions from
intestinal resection (short bowel syndrome) to
inflammatory bowel disease in children.85–91
C8: PTD related to pediatric malignancies (such
as leukemia and neuroblastoma) constantly asso-
ciated with hyperlactatemia and patients under-
going bone marrow transplant (7%).92–107 Of
note, three cases of drug-induced TD (namely,
methotrexate and metronidazole) have been
included in this review.87,93,101
C9: PTD related to acute critical illnesses,
including pediatric emergency room, surgical
setting, pediatric intensive care unit (PICU),
pediatric cardiology and nephrology/dialysis
units, imaging facilities, and other subspecialty
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Figure 4. Proportion of themain clinical manifestations of pediatric thiamine deficiency described in the included studies (each
case can have one or more signs).
emergency platforms (23%). This category gath-
ers diverse pathologies of various degrees of
severity occurring in the very preterm neonatal
period until late adolescence. Diverse TD expres-
sions are described, with clinical, biological
(associated hyperlactatemia), and radiologi-
cally specific or atypical signs of TD. The cases
cover a broad panel of clinical manifestations:
shock, pulmonary arterial hypertension, Shoshin
beriberi, type B lactic acidosis (reversible by
thiamine administration), altered mental status
that can progress to coma, limb weakness, ocular
abnormalities, and signs of truncated or the
entire triad of WE.23,108–127
C10: PTD related to a few documented cases of
autistic spectrum disorders associated with TD
and a case of botulism associatedwith thiaminase
production (2%).128–132
In summary, as opposed to LMICs, many cases of
PTD in HICs occur in childhood and adolescence.
Both age groups seem to display different underly-
ing medical conditions leading to TD.
Clinical manifestations of PTD
Aside from the case series and reports of disabled
patients following TD neurological insults during
early infancy, as well as those with entry points of
medical imaging or post mortem studies, the main
clinical conditions/signs reported are displayed in
Figure 4 (expressed in percentage, where each case
can present with one or more of these condi-
tions/signs).
Acute or insidious onset. Contrary to the main-
stream medical belief that WE is limited to adults,
this study highlights that acute or insidious-onset
WE is the most frequent initial sign. Indeed,
42 out the included 110 studies describe full or
truncated WE, which can benefit from a cerebral
imaging investigation. The clinical presentation
of PTD is broad: severe or refractory underly-
ing TD-associated hyperlactatemia with acidosis,
non-Wernicke neurocognitive signs (sensorimo-
tor signs or ataxia, altered consciousness, ocular
signs, seizures, and dysarthria), and cardiovascular
disorders (critical heart failure and shock). Special
attention should be given to pulmonary arterial
hypertension, remarkably reversed by thiamine
supplementation. Failure to thrive is frequently
reported and should not be forgotten, as it is a com-
mon source of medical referral to pediatricians.
Long-term sequelae. These mostly include
encepalopathy, epilepsy, and language disorders.
Small outbreaks of classic beriberi in breastfed
infants from thiamine-deficient mothers in the
French islands of Mayotte,133 and the unfortu-
nate incident of thiamine-deficient soy-based
infant formula in Israel30 that jeopardized the
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neurocognitive outcomes of young patients in the
long term, remind the medical community that the
classic forms of beriberi in their most detrimental
outcomes can still occur in HICs.
It should be also noted that in Israel a number of
infants who received the same thiamine-free, soy-
based formula but whowere asymptomatic still pre-
sented with later gross- and fine-motor function
alterations and learning difficulties.27,134
PTD caused by genetic inborn errors of thi-
amine metabolism cases (C1) can occur in HICs
and especially in migrant and/or consanguineous
families.31,32
Response to thiamine supplementation
We chose the following criteria to report whether
the patients responded to thiamine supplemen-
tation, as it is not always been clearly docu-
mented: the authors’ judgment, clinical or radio-
logical signs of improvement, lactatemia dynamics,
anemia response, and change in the required dose of
insulin or vasopressor drugs in response to thiamine
(Tables S1 and S2, online only). A positive clinical
response to thiamine administration was identified
in 90 of the 110 reports in this review (82%).
Discussion
Despite the heterogeneity in the methodology of
reports, they have been grouped into 10 categories
(C1–C10) of main underlying conditions poten-
tially leading to PTD. Some case reports could fit in
two or more categories, but in order to avoid confu-
sion, theywere classified in only one category. These
underlying conditions may have one or multiple
pathophysiological mechanisms that can lead to
TD: (1) low vitamin intake (i.e., an absolute insuffi-
ciency in exogenous thiamine intake through foods,
drinks, mother’s deficient milk, EN or TPN, and/or
poor intestinal absorption via impaired intestinal
thiamine absorption regardless of the cause); (2)
thiamine to caloric ratio imbalance (i.e., an inad-
equate thiamine intake in comparison with the
amount of energy consumed or a mismatch with
endogenous hypermetabolic requirements, such in
fever, severe illnesses, and infections); (3) cellular
machinery dysfunction (i.e., a defect in thiamine
transport or an impaired cellular utilization due to a
reduced level of thiamine pyrophosphate, the active
intracellular form of thiamine); (4) excessive losses
(i.e., increased renal or digestive loss, as in renal or
peritoneal dialysis, or use of diuretics, or by recur-
rent diarrhea or vomiting, or postsurgery-induced
hyperemesis); and (5) metabolites or drug interac-
tions with thiamine metabolism (i.e., oxythiamine,
thiaminase, or methotrexate and metronidazole).
The fact that one third of the publications are
from the United States can be explained by many
factors and does not necessarily represent a higher
prevalence of PTD in this country. First of all,
although there were no language restrictions, most
included publications were written in English. The
impact of the modern lifestyle on pediatric non-
communicable diseases (NCDs), such as severe obe-
sity and type 2 diabetes, but also diet and drinking
habits (of sugar-sweetened drinks) in young chil-
dren and adolescents, is particularly noted in the
United States. There is likely a reporting bias as the
pediatric workforce in the United States is one of
the highest in the world; as such, access to pediatric
research is common, and therefore the reporting of
PTD is likely to be higher.
PTD age-related specific vulnerability in HICs
In neonates, the category C1 shows a predominant
proportion of genetic thiamine disorders with a
fixed incidence related to the four most common
mutations. They are usually managed by neonatolo-
gists and geneticists. The current state of wide glob-
alization is associated with increasing movement
of populations; and cases affected by these hered-
itary disorders, enhanced by consanguinity, might
appear in locations where it has not been described
previously.31,32 These rare conditions need urgent
management as some of them respond to thiamine,
such as TRMA. The advances in modern neona-
tal care have also increased the survival rate of
extremely low birth weight preterm babies who are
also at high risk of developing TD through a com-
bination of several complex factors, including very
limited thiamine stores and organ immaturity with
rapid growth. Therefore, they exhibit a significant
dependence on the dual-nutrient “carbohydrate-
thiamine” supply,135 and inadequate intake or mis-
match (not enough thiamine supply compared with
carbohydrate supply) with TPN or EN can lead to
severe TD.62,67
Children and adolescents represent 65% of all
reported cases in this study. In infancy, three cat-
egories are predominantly represented (C1, C5,
and C9). In childhood, four categories clearly
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emerged as prominent causes of TD. Category C0,
corresponding to the follow-up of patients who sur-
vived TD insults during infancy, is the predominant
category, followed by critically ill children in several
emergency and subspeciality settings (C9), children
on TPN or EN (C4), and then soft drinks habits,
as in category C5. The adolescence period is domi-
nated by anorexia (C6) and the combined categories
C2 and C3, both related to NCDs.
Thus, the age of the population appears to be
the most important determinant that has shaped
the current pattern of PTD in HICs, out of the
classic TD forms that previously prevailed and still
remain in LMICs. The age groups mostly affected
by PTD display a shift from early infancy (fre-
quently observed in LMICs) toward childhood and,
to a lesser extent, adolescence (in HICs). Another
potential explanation for this difference is the higher
diagnostic capacity of PTD in HICs, representing a
potential bias. It is possible that if those diagnostic
capacities were available/accessible in LMICs, more
children and adolescents could be diagnosed with
PTD.
Impact of the modern lifestyle in HICs and the
growing burden of NCDs on thiamine
metabolism in pediatrics
Excessive consumption of soft drinks in the pedi-
atric population. This literature review raises two
important points about two periods of the pediatric
lifespan.
On the one hand, there is the description of a
rapid onset of acute TD in infants who have an
excessive consumption of soft drinks, as shown
in category C5. Okumura et al. report a series of
concerning and ongoing PTD cases in Japanese
infants and young children (7–30 months old) as a
result of regular consumption of an average of 1000
mL/day of iso-/hypotonic soft drinks in nonnurtur-
ing environments.77 Reports include cases of heart
failure, pulmonary arterial hypertension, and WE
consistently reversed with additional thiamine, and
neurological sequelae and death in some.
On the other hand, there is the slow build-
up, insidious TD resulting from the consumption
of sweetened sugar drinks in childhood and ado-
lescence. Continuing from childhood habits, the
obesogenic effect of sugar-sweetened beverages is
extended into adolescent dietary patterns associated
with the consumption of carbonated soft drinks and
calorie-dense snack foods.136–141 Without thiamine
supplementation, this can lead to PTD. The avail-
ability of varied and balanced diets, such as those
provided by school meal programs, may mitigate
the expression of TD, rarely overtly observed in
this population. Adolescent binge drinking, often
associated with excessive carbohydrate consump-
tion, puts this group at risk of TD and particularly
of WE.78,142
Diabetes. During the last twodecades, the burden
of type 2 diabetes and “diabesity” (the association
of obesity with type 2 diabetes) has dramatically
increased.143–146 Pediatric type 1 diabetes incidence
is also increasing, and almost half of them are in
European or North American countries.147
DKA is the most common life-threatening com-
plication of pediatric type 1 diabetes and is occa-
sionally associated with cerebral damage,148,149 and
it has been described in all age ranges, includ-
ing in neonatal diabetes associated with TRMA
syndrome.31,34,148 Ketoacidosis is a common rea-
son for the discovery of diabetes in children and
results in a subclinical cerebral edema that pro-
gresses (even in the first hours of insulin therapy) to
encephalopathy.55,56,149 The DKA-related cerebral
edema associated with hyperlactatemia is still not
completely understood in some respects.150,151 In
addition to osmotherapy,148,152 recent data suggest
that thiamine might have a potential adjuvant role
in the global management of DKA55,148,150,153,154 A
positive correlation is also observed between dias-
tolic myocardial dysfunction and serum thiamine
levels in children with DKA.155 Thus, converging
evidence suggests that thiamine may exert a ben-
eficial effect in the management of DKA in chil-
dren and even those with TRMA.34,56,155 Unlike in
adults, no studies have addressed the potential effect
of thiamine to prevent specific complications in the
course of chronic pediatric diabetes.156–158
Severe obesity and bariatric surgery. The preva-
lence of overweight and obesity in children is
plateauing after many years of sharp increase in
HICs.159,160 However, morbid obesity still contin-
ues to grow silently in an obesogenic environment,
most notably in 12- to 19-year-olds.159,161,162
Despite multidisciplinary programs to manage
pediatric obesity, bariatric surgery is one of the
primary management methods. Operations are
costly and constraining, using either restrictive or
64 Ann. N.Y. Acad. Sci. 1498 (2021) 57–76 © 2021 The Authors. Annals of the New York Academy of Sciences
published by Wiley Periodicals LLC on behalf of New York Academy of Sciences
Rakotoambinina et al. Pediatric thiamine deficiency in high-income countries
gastrointestinal bypass procedures now extensively
performed by well-trained surgeons in HICs, even
in pediatric populations.163
It is a common belief that TD after bariatric
surgery is a frequent complication that occurs insid-
iously within 6 months after surgery in pediatrics,
as in adults. No recent large studies or cohorts
have yet established the true prevalence of TD in
pediatric bariatric surgery patients.164 Conversely,
the literature abounds with scattered and some-
what informative case reports on TD in obese chil-
dren after pediatric surgery,58,164 requiring mulidis-
ciplinary teams. Postbariatric TD usually presents
as episodes of repetitive, uncontrolled diarrhea or
vomiting, associatedwithminor neuropathic symp-
toms or atypical ocular signs, or full blown WE.165
Our review suggests that most cases ofWE occur in
adolescents, indicating a profound depletion of the
body’s thiamine reserves over time.
Deficiencies of micronutrients, including vita-
mins D and B12, folate, iron, and thiamine, are
also reported prior to bariatric surgery, likely due to
attempts to lose weight tied to self-induced vomit-
ing or an unbalanced diet.166
Eating disorders and anorexia. Anorexia in ado-
lescence (C6) occupies a predominant proportion of
cases in this review. In most HICs, these patients
are managed by specialized multidisciplinary eat-
ing disorder units. Eating disorders, including
anorexia, have also become a significant public
health issue among adolescents in the industri-
alized world167–169 and middle-income countries
(MICs)170 They affect mostly girls, with an initial
onset between 10 and 20 years of age and a peak
age of onset in early to mid-adolescence, according
to studies in six European countries.171 Two stud-
ies have described a variable frequency of anorexia-
related TD of between 10% and 32%.79,83 Anorexia
is a complex neuropsychiatric disorder with multi-
factorial components (sociocultural, epigenetic, and
genetic).172 Our review shows that anorexia is asso-
ciated with various phenotypes of TD, WE being
the culminating neurological presentation associ-
ated with other reported minor neuropsychiatric
symptoms.79–82,84 The multiple mechanisms lead-
ing to TD in anorexia include malnutrition asso-
ciated with poor intake, as well as laxative use
and self-induced vomiting in patients with purg-
ing behaviors. A hypothesis for the occurrence of
WE could be that pronounced depletion of thi-
amine stores and inadequate intake of thiamine
affects the brain that is still undergoing maturation
in adolescence7,10 An underlying genetic error of
thiamine metabolism has been described in some
patients, making them more susceptible to any
thiamine-deficient diet.19,172,173 Refeeding requires
special attention in these cases.174
To what extent can higher diagnostic
capacities in HICs influence the detection of
clinical expressions of PTD compared with
resource-limited settings?
The classic TD clinical spectrum is summarized in
Figure 5. These clinical presentations are discussed
in recent publications.9,175,176
Classic infantile beriberi. Classic infantile
beriberi in early months of infancy caused by
feeding by thiamine-deficient mothers is very
rarely observed in HICs. Only two sets of cases
are reported in this review. The first occurred on
an epidemic scale in families living in disadvan-
taged socioeconomic conditions on the French
island of Mayotte. Some sporadic cases have also
been observed in the island of Reunion.109,133 The
second case series is related to the unfortunate
case of infants fed thiamine-deficient soy milk
formula, which occurred on a large scale in Israel
in 200330,122 and had a major long-term impact, as
discussed below.
In this study, there was no report of the nonspe-
cific signs associated with infant TD, such as loud
piercing cries, colic, refusal to breastfeed, vomit-
ing, and agitation.177,178 Nevertheless, our current
review may suffer from underreporting of this early
form of TD because most studies originate from
specialized settings and not fromprimary care pedi-
atrics. Few available studies have addressed the issue
of the micropockets of poverty that are consis-
tently present in the large megacities of rich coun-
tries. This context specifically relates to the hidden
and high-risk young population susceptible to over-
looked multiple nutritional deficiencies, in addition
to infectious and/or respiratory diseases within the
general framework of pathology affecting minority
families, poor migrants, and even homeless breast-
feeding women, who can be marginalized from
access to primary and specialist care.179–182
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Figure 5. Clinical spectrum of classic thiamine deficiency. Reproduced from Ref. 9.
Cardiovascular beriberi. Cardiovascular beri-
beri consists of the onset of heart failure, which can
occur suddenly. It is described as hyperlactatemia
associated with a high-output cardiac failure, pre-
dominantly in the right or both cardiac chambers,
and in its edematous form with a pitting edema
in the lower limbs. The outcome can be exacer-
bated by loop diuretics without prompt thiamine
administration.66,113,114,125
One of the major findings was the occur-
rence of acute respiratory distress in tachycardic
infants, expressed as a pulmonary arterial hyper-
tension with hyperlactatemia, which is remark-
ably reversed by thiamine treatment, as noted
earlier.72,74,111,125,127,131
The popularization of pediatric bedside car-
diac Doppler ultrasound in infants and the readily
available assay of lactate point-of-care testing have
allowed such a refined diagnostic and therapeutic
achievement, which is becoming routine practice
in HICs.183 However, case reports of TD related
to pulmonary arterial hypertension were emerg-
ing not long ago in MICs, where ultrasound car-
diac Doppler and trained local staff are becoming
more available.184–186 This highlights that LMICs
and HICs differ more from diagnostic capacities
than clinical presentations.
Neurological signs of PTD. Early minor mani-
festations of TD neuropathy are characterized in
this review by symmetrical sensory-motor impair-
ments (such as muscle pain and weakness),84
dysarthria, dysfunction or paralysis of the lower
extremities, progressive (gait) ataxiawith orwithout
inaugural signs of encephalopathy, and decreased
deep tendon reflex function of the extremities,
affecting mainly the lower limbs. This can progres-
sively lead to altered consciousness.80,82,84,108,122
The diagnosis of unexplained severe neurological
signs of encephalopathy can benefit from modern
neuroimaging and/or response to thiamine admin-
istration or both. In this review, there is no report of
pseudo-meningitic forms that usually occur around
6−12 months of age.8,187 WE was the most frequent
manifestation of TD in our review (Fig. 4), which
can occur at any age,57,89 but a significant subset of
the reports in this review are during adolescence,
as seen in categories C7–C9, as opposed to infancy
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in LMICs.188,189 Its onset can have a rapid progres-
sion, with or without ataxia, and can be associated
with other minor clinical manifestations, including
muscular fasciculation or weakness, atypical ocular
symptoms, nystagmus, ophthalmoplegia, seizures,
and altered mental status until coma.59,61,65,122,173
The main causative pathological conditions in our
review were from anorexia, morbid obesity, and
bariatric surgery; all of them are caused by an insuf-
ficient supply of thiamine tied to the lack of risk
awareness.62,90,105
In pediatric medical imaging platforms, as found
in tertiary hospitals in HICs, the imaging modal-
ities are useful tools for assessment and making a
rapid as well as decisive diagnosis of PTD. Mag-
netic resonance imaging (MRI) is more available
and feasible inHICs as a screeningmodality because
of its greater diagnostic potential over CT. In adult
studies, the MRI sensitivity is 53%, but its speci-
ficity is 93%, with a positive predictive value of
89%.190 However, it is now widely used in pedi-
atrics in HICs.191 Unlike in adults, the pediatric
brain MRI of Wernicke-like syndrome can display
peculiar lesions in the frontal lobe and basal gan-
glia, notably the striatum and putamen, all of these
regions being sensitive to thiamine deprivation.
Atypical lesions can also be located in the cerebel-
lum. An evaluation of the cortex serves as an indi-
cator of prognosis.191–193 However, adults and chil-
dren affected by TD show the same symmetrical
high-intensity signal on T2 weighting in mammil-
lary bodies and periaqueductal and thalamic areas,
sites of neuronal damage, and disruption to myeli-
nation confirmed by cerebral spectrumMRI.
Additional diagnostic tools can also be useful in
identifying and characterizing TD. Cranial trans-
fontanelar ultrasound in infants could be an alter-
native to MRI, as it can be performed at the bed-
side (point of care), revealing hyperechoic lesions
of the basal ganglia.188 Other techniques, such as
the use of contrast enhancement, fluid-attenuated
inversion recovery (FLAIR) images, and diffusion-
weighted imaging,194 as well as MR spectroscopy
(displaying high lactate peaks),195 have additional
diagnostic value.195 In addition, MRI can be used
to monitor in situ recovery of neurological damage
during thiamine treatment.191,196
The MRI findings in HICs and LMICs are simi-
lar, with basal ganglia involvement (especially puta-
men and caudate nucleus20,77,189,191), and the two
differ largely by the accessibility of such neu-
roimaging tools. Some differences found between
LMIC and HIC cohorts189 regarding less involve-
ment of other cerebral regions (e.g., mammillary
bodies and periaqueductal gray matter) might be
explained by multiple factors. Mammillary bod-
ies and periaqueductal area abnormalities seem
to be more frequent in children and adoles-
cents than in young infants.23,60,61,68,82 Similarly,
nutrition, environment, and genetic diseases (such
as Leigh syndrome) potentially overlapping with
the TD spectrum might also contribute to these
differences.188,189,197 MRI protocols, such as con-
trast enhancement, might increase the sensitivity
for mammillary bodies detection and has not been
used systematically in some studies.20,23,198–201
Neurological presentations, such as WE in ado-
lescents, seem more frequent in HICs than in
LMICs, but this may be biased as neuroimaging is
the standard of care in HICs and has contributed
significantly to its diagnosis.
Long-term neurological sequelae (C1) was
the most commonly reported of the categories
in children. It includes outpatient care in pedi-
atric neurology departments, or follow-up in
pediatric neurological services or neuroimaging
department.26,27 They are investigated in the neu-
rolinguistic and psychological settings for their
alteration in the syntactic and lexical modalities
of language acquisition.28 Most overt symptomatic
cases who survived later developed complications
in the form of epilepsy or lack of acquisition of
developmental milestones.29 Some children also
presented permanent auditory dysfunction.134
A number of infants who received this thiamine-
deficient soy-based formula in Israel, but who were
initially asymptomatic still presented years later
with gross- and fine-motor function alterations and
learning difficulties.9,28 This reflects how important
thiamine is for children’s overall neurodevelopment,
and it highlights the importance of early diagnosis
of TD and subclinical TD during this critical period
in infancy of neurodevelopment that involves the
acquisition of cognitive skills. In utero exposure to
TD may also lead to fetal brain dysfunction, as
observed in fetal alcohol syndrome.202
This nutritional incident in Israel has proba-
bly contributed to reducing the extent of TD in
infants in HICs because many national regulatory
agencies in every industrialized country, the major
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international pediatric societies, and the infant for-
mula industry have compliedwith the currentmini-
mum standards for infant formula,203 in addition to
the WHO promotion of breastfeeding in the first 6
months of life. However, such poor outcomes may
be the fate of children from very underprivileged or
homeless families who gradually develop TD, which
can be expressedmonths or years later as neurocog-
nitive disabilities.182
High-level medical management of pediatric
complex illnesses can be associated with
PTD in HICs
Most of the cases from this review occurred in
high-level tertiary centers, as opposed to classic
beriberi in LMICs that tends to occur in primary
settings. This is in line with the Lallas and Desai
review173 that describes WE in children and that
points out three main scenarios, such as bariatric
surgery, malignancies, and intensive care manage-
ment. Our study reveals similar findings with more
recent and detailed categories.
Owing to the increasing prevalence of morbid
obesity and the recent advances in bariatric surgery
procedures,204 more and more adolescents follow
this option, as represented by the C3 category.
Bariatric surgery is a highly specialized, requir-
ingmultidisciplinary teams, including nutritionists,
among other specialists. The reduction of both thi-
amine absorption following surgery and thiamine
intake in the first months can lead to severe TD,
including WE.57–61
Categories C8 and C9 include diverse critical
conditions that increase the risk of developing
TD. Many highly specialized pediatric services
were involved in these categories: oncology units,
pediatric emergency rooms, PICUs or neonatal
intensive care units, specialized surgical services
(abdominal, cardiac, and transplantation), gas-
troenterology, and imaging and dialysis units. This
is also reflected by the large number of different
critical conditions, including cases of coma, shock
with hyperlactatemia, heart failure, pulmonary
arterial hypertension detected by color Doppler
sonography, postsurgical nutritional complica-
tions, nephrological cases, and neurological cases
with minor sensorimotor signs or atypical or full
WE.23,91,110,111,116,119,123,125,126,131
In these categories, multiple pathogenic mecha-
nisms leading to TD are often involved. This can
be observed in postsurgical cases of heart oper-
ation or organ transplantation.119 The predomi-
nant cause is a mismatch between an increased
metabolic demand and an inadequate thiamine
availability. This can be caused by the coexistence
of underlying malabsorption or excessive diges-
tive or renal loss of thiamine, and/or insufficient
removal of oxythiamine (a uremic toxin inhibiting
transketolase), as in end-stage renal disease.205–207
As such, an unusual cluster of TD cases has been
reported to be mostly tied to advanced techniques
in dialysis or hemofiltration.114,121,126 Such a sub-
category of PTD risk linked with end-stage renal
diseases has not been fully delineated by Lal-
las and Desai,173 while there has been significant
and incremental advances in renal replacement-
dialysis modalities (peritoneal dialysis, intermit-
tent hemodialysis, and continuous and hybrid
therapies).208
C4 is represented by a set of reports of neonates
and infants/children on TPN or EN with poor thi-
amine intake or increased intestinal losses in which
TD appears after insufficient thiamine supply in
therapeutic feeding.62,67
Critically ill patients, often malnourished and/or
on prolonged TPN, have complex metabolisms
that can be further compromised by receiving
polychemotherapy that can interact with thiamine
metabolism: diuretics, proton pump inhibitor
drugs, metronidazole and some other antibiotics,
tacrolimus, cyclosporin,209,210 5-fluorouracil, and
methotrexate,93,101 among others. This is repre-
sented to some extent in our C8 category, especially
in perioperative bone marrow transplantations;
however, drugs that potentially interact with thi-
amine metabolism are not uncommon in other
categories. Transient reduction of micronutrients
has been described in systemic inflammation,211–213
and Peixoto de Lima et al. described an independent
correlation with C-reactive protein (CRP) levels
and TD.214 In this review, very few reports mention
CRP monitoring,70,85–87,117,127 and none monitored
CRP and thiamine trends simultaneously, apart
from Peixoto de Lima et al. The not insignificant
consequences of transient TD on children’s devel-
oping brains are difficult to document in daily
clinical practice as no clinician would take the
risk of delaying such treatment (due to the poten-
tial long-term sequelae that have been described
even in initially asymptomatic thiamine-deficient
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infants, as documented in the C0 category of this
study).
While the major cause of classic diet thiamine
deprivation is no longer relevant in 2020 in HICs,
this study has revealed a small but noticeable num-
ber of PTD cases arising from critical illnesses or
chronic conditions that are managed in highly spe-
cialized pediatric services. All of these patients suf-
fer various risks of PTD.
Strengths and limitations
Strengths. This up-to-date review is a condensed
and unique study that comprehensively addresses
complex PTD issues, including age, clinical presen-
tation, and predisposing risk factors, observed in
HICs.
Limitations. First, as this is not a systematic
review, the number of retrieved articles cannot
reflect the magnitude or prevalence of overall PTD
in HICs. The number of countries included in this
review accounts for only 28% of the total HICs,
according to the World Bank.25 We also excluded
opinion pieces and commentaries, which do not
constitute original research.
Second, the included studies are only case stud-
ies and series, which are not evidence of the best
quality (i.e., high-quality, randomized clinical tri-
als or systematic reviews). Nevertheless, they should
not be excluded from scientific consideration. These
instructive case series or reports deal with facts and
are based on observational data, so they remain
illustrative of the real world of medical practice in
PTD issues.
Third, the methodology of using a compilation
of several scattered cases led to a high level of clini-
cal heterogeneity. Nevertheless, in light of the likely
low prevalence of the phenomenon, this method
proves to be the only pragmatic approach to account
for it. They result in concordant PTD observations
encountered all over the world within the limited
circle of HICs.
Conclusion
This study provides an updated and holistic
overview of PTD in HICs over the last two decades
and highlights two paradigm changes. First, there
is a clear shift toward older children as opposed
to young infants, as seen in LMICs. Second, mul-
tiple underlying conditions, either individually
or concomitantly, can lead to PTD in HICs, such
as anorexia, critical illnesses, malignancies, and
renal replacement therapies. The growing burden
of NCDs, such as morbid obesity, is beginning to
have an impact on PTD. In addition, this study
supports the idea that the nervous system, notably
the growing brain, is a crucial target of thiamine
deprivation among the pediatric population. WE
is the predominant manifestation of PTD, and its
early signs need to be known in order to avoid
long-term sequelae. Neuroimaging with MRI is a
common diagnostic tool, with characteristic TD
findings that allow clinicians to monitor treatment
response as well. PTD is mostly described in high-
level tertiary centers, where medical awareness
needs to be high as PTD can also be associated with
complex medical management. The number of
children with neurocognitive disabilities, followed
up after an overt clinical or subclinical TD insult
that occurred during early infancy, should call
for special attention toward the most vulnerable
populations in HICs, including pregnant migrant
women and young infants living in precarious
conditions in HICs.
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